COMP <GO>
AHR vs JPM // OPERATING MARGIN
American Healthcare REIT Inc. (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: AHR 5
— JPM 9
▲ OPERATING MARGIN LEADER: JPM
LAST: $53.52 (+1.10%) • MKT CAP: $12.34B
operating-margins
19.80%
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
operating-margins
42.07%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHR VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHR | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.10% | 17.37% | -9.27 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.4x | 9.7x | +16.73 | JPM | /valuation <GO> |
| Free Cash Flow Yield | 1.62% | -18.14% | +19.76 | AHR | /fcf-yield <GO> |
| Operating Margin ACTIVE | 19.80% | 42.07% | -22.27 | JPM | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 32.63% | -29.23 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 13.53% | -2.33 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.32% | 1.96% | -0.64 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.12 | 0.37 | +3.75 | AHR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | AHR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 4.84% | +2.46 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 49.0 | +5.59 | AHR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.00 | +0.11 | AHR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 13.6x | +126.43 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.34B | $895.92B | -$883.57B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHR REV | JPM REV | AHR GROSS % | JPM GROSS % | AHR FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | $182.45B | 14.4% | — | $200.2M | -$147.78B |
| FY 2024 | $1.88B | $177.56B | 12.2% | — | $91.3M | -$42.01B |
| FY 2023 | $1.67B | $158.10B | 44.0% | — | $23.4M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHR // BETA 1.11
JPM // BETA 1.00